Recite me link

Q1. How many patients have been treated in the last 6 months for Urinary Tract Infections (ICD10 code N39.0) with the following?
a. Ceftazidime/avibactam (Zavicefta)
b. Ceftolozane/tazobactam (Zerbaxa)
c. Meropenem/vaborbactam (Vaborem)
d. Cefiderocol (Fetcroja)
e. Meropenem
Q2. How many patients have been treated in the last 6 months for Post-procedural Respiratory Disorders (ICD10 code J95.8) with the following?
a. Ceftazidime/avibactam (Zavicefta)
b. Ceftolozane/tazobactam (Zerbaxa)
c. Meropenem/vaborbactam (Vaborem)
d. Cefiderocol (Fetcroja)
e. Meropenem
Q3. How many patients have been treated in the last 6 months for Hospital Acquired Pneumonia (ICD10 codes J15 and Y95 in the same inpatient spell) with the following?
a. Ceftazidime/avibactam (Zavicefta)
b. Ceftolozane/tazobactam (Zerbaxa)
c. Meropenem/vaborbactam (Vaborem)
d. Cefiderocol (Fetcroja)
e. Meropenem
Q4. How many patients who underwent a laparotomy/laparoscopic approach to the abdominal cavity (any one of OPCS codes Y502, Y751, Y752 or Y755) in the last 6 months, were treated with the following?
a. Ceftazidime/avibactam (Zavicefta)
b. Ceftolozane/tazobactam (Zerbaxa)
c. Meropenem/vaborbactam (Vaborem)
d. Cefiderocol (Fetcroja)
e. Meropenem

Download response Anti-infective medications. 090421